Application 021316

Type
NDA
Sponsor
COVIS PHARMA BV

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ALTOPREVLOVASTATINTABLET, EXTENDED RELEASE;ORAL10MGNoNo
002ALTOPREVLOVASTATINTABLET, EXTENDED RELEASE;ORAL20MGYesNo
003ALTOPREVLOVASTATINTABLET, EXTENDED RELEASE;ORAL40MGYesNo
004ALTOPREVLOVASTATINTABLET, EXTENDED RELEASE;ORAL60MGYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021316-001ALTOPREVLOVASTATIN10MGTABLET, EXTENDED RELEASE / ORAL2002-06-26
N021316-002ALTOPREVLOVASTATIN20MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26
N021316-003ALTOPREVLOVASTATIN40MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26
N021316-004ALTOPREVLOVASTATIN60MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N021316-001ALTOPREV10MGTABLET, EXTENDED RELEASE / ORAL2002-06-2684e616aacf4f…
2026-09-14 22:38:342026-08N021316-002ALTOPREV20MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-2684e616aacf4f…
2026-09-14 22:38:342026-08N021316-003ALTOPREV40MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-2684e616aacf4f…
2026-09-14 22:38:342026-08N021316-004ALTOPREV60MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-2684e616aacf4f…
2026-08-18 06:07:402026-07N021316-001ALTOPREV10MGTABLET, EXTENDED RELEASE / ORAL2002-06-26caaa826d4ba7…
2026-08-18 06:07:402026-07N021316-002ALTOPREV20MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26caaa826d4ba7…
2026-08-18 06:07:402026-07N021316-003ALTOPREV40MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26caaa826d4ba7…
2026-08-18 06:07:402026-07N021316-004ALTOPREV60MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021316-001ALTOPREV10MGTABLET, EXTENDED RELEASE / ORAL2002-06-26011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021316-002ALTOPREV20MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021316-003ALTOPREV40MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021316-004ALTOPREV60MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021316-001ALTOPREV10MGTABLET, EXTENDED RELEASE / ORAL2002-06-2631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021316-002ALTOPREV20MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-2631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021316-003ALTOPREV40MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-2631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021316-004ALTOPREV60MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-2631067a03dcf5…
2025-08-23 18:47 UTC2025-08N021316-001ALTOPREV10MGTABLET, EXTENDED RELEASE / ORAL2002-06-266a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021316-002ALTOPREV20MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-266a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021316-003ALTOPREV40MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-266a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021316-004ALTOPREV60MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-266a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021316-001ALTOPREV10MGTABLET, EXTENDED RELEASE / ORAL2002-06-26fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021316-002ALTOPREV20MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021316-003ALTOPREV40MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021316-004ALTOPREV60MGTABLET, EXTENDED RELEASE / ORALRLD, RS2002-06-26fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021316-001ALTOPREV10MGTABLET, EXTENDED RELEASE / ORAL2002-06-26b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021316-002ALTOPREV20MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021316-003ALTOPREV40MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-26b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021316-004ALTOPREV60MGTABLET, EXTENDED RELEASE / ORALRLD, RS2002-06-26b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021316-001ALTOPREV10MGTABLET, EXTENDED RELEASE / ORAL2002-06-2603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021316-002ALTOPREV20MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-2603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021316-003ALTOPREV40MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-2603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021316-004ALTOPREV60MGTABLET, EXTENDED RELEASE / ORALRLD, RS2002-06-2603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021316-001ALTOPREV10MGTABLET, EXTENDED RELEASE / ORAL2002-06-262680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021316-002ALTOPREV20MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-262680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021316-003ALTOPREV40MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-262680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021316-004ALTOPREV60MGTABLET, EXTENDED RELEASE / ORALRLD, RS2002-06-262680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021316-001ALTOPREV10MGTABLET, EXTENDED RELEASE / ORAL2002-06-265bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021316-002ALTOPREV20MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-265bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021316-003ALTOPREV40MGTABLET, EXTENDED RELEASE / ORALRLD2002-06-265bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021316-004ALTOPREV60MGTABLET, EXTENDED RELEASE / ORALRLD, RS2002-06-265bbf6a4d5a75…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 3 · 56 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LovastatinLOVASTATINREMEDYREPACK INC.9438d8a0-ca5b-4676-aab9-d0241ccff6c92026-07-23Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINPD-Rx Pharmaceuticals, Inc.e75b5808-ec66-4da7-90bc-e53611aa1b342026-06-12Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINPreferred Pharmaceuticals Inc.56680dfa-abe6-4587-b222-364315fd78f42026-06-03Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINPreferred Pharmaceuticals, Inc.397949f9-ce60-424f-9902-90e65a34f4de2026-06-03Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINPreferred Pharmaceuticals, Inc.22c9f2d8-7bcd-4415-bbc8-5057200339662026-06-03Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINPreferred Pharmaceuticals, Inc.ea4df37b-21e9-4dc3-83af-1be1b50bfdc92026-06-03Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINBryant Ranch Prepack030c0f79-6bb5-4876-bf8e-b7a25b25dd382026-05-29Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINBryant Ranch Prepackf5f265a6-2aa5-4205-9159-40133ae93ac02026-05-28Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINBluePoint Laboratories7b86160d-74a9-4774-b5b3-5641e686991f2026-05-27Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINREMEDYREPACK INC.ff040b3c-6790-40d7-bd64-a4073b4a20452026-05-21Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINLupin Pharmaceuticals, Inc.df7ddf4f-d569-431e-81f1-9129d70431502026-05-06Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINREMEDYREPACK INC.a902a95f-072a-4487-99a9-109a93f8b23c2026-04-03Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINLegacy Pharmaceutical Packaging, LLCa4f02fa1-3281-46fa-bd52-323e2644b6f82026-03-11Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINBryant Ranch Prepack7fd9d5c7-8025-4049-8b5b-ae3d22db507f2026-03-09Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINNorthwind Health Company, LLCf308fe1c-23a9-6409-e053-2995a90abfd92026-01-01Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINNorthwind Health Company, LLCca59cbd4-a4c1-aebe-e053-2a95a90ae9682026-01-01Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINNorthwind Health Company, LLCdb47ddae-c574-427f-e053-2a95a90aae482026-01-01Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINNorthwind Health Company, LLCf99e0b4c-e757-4ccd-e053-6294a90ab7222026-01-01Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINGolden State Medical Supply, Inc.91332c54-1a27-4e6b-e053-2a95a90a42cd2025-12-15Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN
LovastatinLOVASTATINA-S Medication Solutions06b8c398-ce2e-42c1-b1a8-73cc59a080db2025-10-15Warnings, Adverse reactionsName fallback
generic name: LOVASTATIN

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 12 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
70515-628AltoprevlovastatinCovis PharmaNDACurrent
70515-628AltoprevlovastatinCovis Pharma US, IncNDACurrent
70515-628AltoprevlovastatinCovis PharmaNDACurrent
70515-628AltoprevlovastatinCovis PharmaNDACurrent
70515-629AltoprevlovastatinCovis PharmaNDACurrent
70515-629AltoprevlovastatinCovis Pharma US, IncNDACurrent
70515-629AltoprevlovastatinCovis PharmaNDACurrent
70515-629AltoprevlovastatinCovis PharmaNDACurrent
70515-630AltoprevlovastatinCovis PharmaNDACurrent
70515-630AltoprevlovastatinCovis Pharma US, IncNDACurrent
70515-630AltoprevlovastatinCovis PharmaNDACurrent
70515-630AltoprevlovastatinCovis PharmaNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
77836SUPPL 2024-03-15
64717SUPPL2020-09-29
64701SUPPL2020-09-28
52805SUPPL2018-03-02
52795SUPPL2018-03-02
49279SUPPL2017-08-08
49269SUPPL2017-08-08
36641SUPPL2014-05-02
27462SUPPL2014-05-01
15171SUPPL2012-12-28
5010SUPPL2012-12-27
27461SUPPL2012-11-05
15172SUPPL2012-11-02
27460SUPPL2012-05-02
15170SUPPL2012-04-27
42094SUPPL2007-07-09
42095SUPPL2007-04-30
5009SUPPL2007-02-12
36640SUPPL2004-07-21
27459SUPPL2004-07-21
5006SUPPL2004-05-28
36639SUPPL2003-09-30
5008SUPPL2003-09-30
5007SUPPL2003-08-28
21594ORIG2003-04-30
15169SUPPL2002-09-11
36638ORIG2002-06-26
5005ORIG2002-06-26